Search | IOVS | ARVO Journals

Showing 1 – 20 of 34

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract July 2019

Preclinical Evaluation of NCX 4251, a Novel Steroid Therapy for Blepharitis, Targeted Directly to the Eyelid Margin to Reduce the Potential for IOP Elevations

Tomas Navratil; Jean-Michel Bukowski; Frederic Pilotaz; Amanda Graves; Akshay Nadkarni; Amber Allen; Brigitte Duquesroix; Elena Bastia; Laura Storoni; Angela Kothe; Michael V W Bergamini; Jay Pennell; Brian G Short; Thomas Walters; Robert D Fechtner; Donald L Budenz

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):6755. doi:

ARVO Annual Meeting Abstract September 2016

Generic glaucoma medication costs: a 2 year analysis

Eunmee Yook; Robert D Fechtner; Albert S Khouri

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):5585. doi:

ARVO Annual Meeting Abstract September 2016

Comparison of visual field artifact from two visual field analyzers

Tamara L Berezina; Albert S Khouri; Catherin Horan; Robert D Fechtner

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3930. doi:

ARVO Annual Meeting Abstract September 2016

Are disposable and standard gonioscopy lenses comparable?

Bonny Lee; Timothy Peiris; Dan Liu; David Atherton; Bernard C Szirth; Robert D Fechtner; Albert S Khouri

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):4671. doi:

ARVO Annual Meeting Abstract June 2015

Sensitivity and Variability of Peripheral Visual Field (PVF) Testing

Tamara L Berezina; Christopher Kuriakose; Albert S Khouri; Robert D Fechtner

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):1058. doi:

ARVO Annual Meeting Abstract April 2014

A self-Tonometer yields low variation and indicates linearity in the elasticity of palpebral tissue

Hassan Muhammad; Roa Al-Abdalla; Reginald Farrow; Albert S Khouri; Robert D Fechtner; Gordon Thomas

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):136. doi:

ARVO Annual Meeting Abstract April 2014

Long term outcomes of Ex-PRESS glaucoma filtration surgery in African American patients with glaucoma

Ann Mary John; Tamara L Berezina; Robert D Fechtner; Albert S Khouri

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):3170. doi:

ARVO Annual Meeting Abstract April 2014

Does Stimulus Size Affect Test-Retest Reliability for Peripheral Visual Field Testing?

Tamara L Berezina; Christopher Kuriakose; Albert S Khouri; Anton M Kolomeyer; Robert D Fechtner

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):5616. doi:

ARVO Annual Meeting Abstract April 2014

Diode CPC Energy Parameters during Treatment of Refractory Childhood Glaucoma

Lekha Ravindraraj; Robert D Fechtner; Albert S Khouri

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):5675. doi:

ARVO Annual Meeting Abstract March 2012

Small Gauge Pars Plana Vitrectomy With Pars Plana Baerveldt Tube Placement For Refractory Glaucoma

Anton M. Kolomeyer; Chris Seery; Chris Seery; Robert D. Fechtner; Marco A. Zarbin; Neelakshi Bhagat

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):3710. doi:

ARVO Annual Meeting Abstract March 2012

Comparison of Ex-PRESS Glaucoma Filtration Device with Trabeculectomy in African American Population: 1 Year Results

Meng Lu; Michelle Pham; Irena Cherfas; Tamara Berezina; Amir Cohen; Robert D. Fechtner; Albert Khouri

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):3726. doi:

ARVO Annual Meeting Abstract March 2012

Primary and Repeat Selective Laser Trabeculoplasty in Pseudophakic Eyes: 2 year follow-up

Tamara L. Berezina; Albert S. Khouri; Barry A. Maltzman; Khelly Shah; Robert D. Fechtner

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):5959. doi:

ARVO Annual Meeting Abstract March 2012

Selective Laser Trabeculoplasty Energy Dose Response - Long Term Results

Larissa A. Gregory; Tamara L. Berezina; Sara Prasertsit; Robert D. Fechtner; Albert S. Khouri

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):5965. doi:

ARVO Annual Meeting Abstract March 2012

Subsequent Slt Can Be Effective After Initially Less Responsive Slt: 4 Year Follow-up

Albert S. Khouri; Tamara L. Berezina; Barry Maltzman; Khelly Shah; Robert D. Fechtner

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):5967. doi:

ARVO Annual Meeting Abstract March 2012

Severity of Ocular Surface Diseases Symptoms is Temporally Associated with the Intensity of Topical Glaucoma Therapy

Hamed B. Lari; Tamara L. Berezina; Albert S. Khouri; Larissa A. Gregory; Daniel Levinsohn; Robert D. Fechtner

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):4480. doi:

ARVO Annual Meeting Abstract April 2011

Duration and Intensity of Glaucoma Topical Therapy is Associated with Severity of Ocular Surface Disease

Hamed B. Lari; Albert S. Khouri; Tamara Berezina; Robert D. Fechtner

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):1961. doi:

ARVO Annual Meeting Abstract April 2011

Long Term IOP Reduction after Second and Third Repeat Selective Laser Trabeculoplasty

Albert S. Khouri; Tamara L. Berezina; Barry Maltzman; Robert D. Fechtner

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):2610. doi:

ARVO Annual Meeting Abstract April 2011

Is There a Selective Laser Trabeculoplasty Energy Dose-Response?

Sara Prasertsit; Larissa Gregory; Albert S. Khouri; Tamara L. Berezina; Barry Maltzman; Robert D. Fechtner

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):2622. doi:

ARVO Annual Meeting Abstract April 2011

Retrospective Efficacy Comparison of Ex-PRESS Miniature Glaucoma Implant with Trabeculectomy

Meng Lu; Michelle Pham; Irena Cherfas; Robert D. Fechtner

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):633. doi:

ARVO Annual Meeting Abstract April 2011

Intraocular Pressure Outcomes Following Endophthalmitis Associated with Glaucoma Surgery

Rana J. Mady; Albert S. Khouri; Bart K. Holland; Lisa M. Athwal; Robert D. Fechtner; Paul J. Lama; Marco A. Zarbin; Neelakshi Bhagat

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):638. doi:

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Preclinical Evaluation of NCX 4251, a Novel Steroid Therapy for Blepharitis, Targeted Directly to the Eyelid Margin to Reduce the Potential for IOP Elevations

Generic glaucoma medication costs: a 2 year analysis

Comparison of visual field artifact from two visual field analyzers

Are disposable and standard gonioscopy lenses comparable?

Sensitivity and Variability of Peripheral Visual Field (PVF) Testing

A self-Tonometer yields low variation and indicates linearity in the elasticity of palpebral tissue

Long term outcomes of Ex-PRESS glaucoma filtration surgery in African American patients with glaucoma

Does Stimulus Size Affect Test-Retest Reliability for Peripheral Visual Field Testing?

Diode CPC Energy Parameters during Treatment of Refractory Childhood Glaucoma

Small Gauge Pars Plana Vitrectomy With Pars Plana Baerveldt Tube Placement For Refractory Glaucoma

Comparison of Ex-PRESS Glaucoma Filtration Device with Trabeculectomy in African American Population: 1 Year Results

Primary and Repeat Selective Laser Trabeculoplasty in Pseudophakic Eyes: 2 year follow-up

Selective Laser Trabeculoplasty Energy Dose Response - Long Term Results

Subsequent Slt Can Be Effective After Initially Less Responsive Slt: 4 Year Follow-up

Severity of Ocular Surface Diseases Symptoms is Temporally Associated with the Intensity of Topical Glaucoma Therapy

Duration and Intensity of Glaucoma Topical Therapy is Associated with Severity of Ocular Surface Disease

Long Term IOP Reduction after Second and Third Repeat Selective Laser Trabeculoplasty

Is There a Selective Laser Trabeculoplasty Energy Dose-Response?

Retrospective Efficacy Comparison of Ex-PRESS Miniature Glaucoma Implant with Trabeculectomy

Intraocular Pressure Outcomes Following Endophthalmitis Associated with Glaucoma Surgery

To View More...

You must be signed into an individual account to use this feature.